Quick Answer
International Stem Cell CORP reported Stockholders Equity of -$4.06 million for the year ending 2025.
- International Stem Cell CORP showed a decrease of -3.3% in Stockholders Equity from 2024 to 2025.
- This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$79.0 thousand | Q2 2015: $805.0 thousand | Q3 2015: $834.0 thousand | Q1 2016: -$12.85 million | Q2 2016: -$982.0 thousand | Q3 2016: $425.0 thousand | Q1 2017: $638.0 thousand | Q2 2017: $1.59 million | Q3 2017: -$186.0 thousand | Q1 2018: $1.64 million | Q2 2018: $1.64 million | Q3 2018: $2.79 million | Q1 2019: -$1.11 million | Q2 2019: -$1.19 million | Q3 2019: -$676.0 thousand | Q1 2020: -$2.84 million | Q2 2020: -$3.61 million | Q3 2020: -$3.88 million | Q1 2021: -$4.70 million | Q2 2021: -$4.31 million | Q3 2021: -$4.36 million | Q1 2022: -$4.51 million | Q2 2022: -$4.42 million | Q3 2022: -$4.65 million | Q1 2023: -$4.45 million | Q2 2023: -$3.85 million | Q3 2023: -$3.86 million | Q1 2024: -$4.26 million | Q2 2024: -$4.02 million | Q3 2024: -$4.04 million | Q1 2025: -$4.09 million | Q2 2025: -$3.90 million | Q3 2025: -$3.78 million.
- Over the full 19 years of available data (2007 to 2025), International Stem Cell CORP's Stockholders Equity has declined by 2,015.1%.
- Historical annual values: Fiscal year 2025: -$4.06 million | Fiscal year 2024: -$3.93 million | Fiscal year 2023: -$4.19 million | Fiscal year 2022: -$4.52 million | Fiscal year 2021: -$4.59 million | Fiscal year 2020: -$4.33 million | Fiscal year 2019: -$2.89 million | Fiscal year 2018: $2.54 million | Fiscal year 2017: $2.06 million | Fiscal year 2016: $3.44 million | Fiscal year 2015: $1.59 million | Fiscal year 2014: $321.0 thousand | Fiscal year 2013: -$4.22 million | Fiscal year 2012: -$1.76 million | Fiscal year 2011: $3.62 million | Fiscal year 2010: $5.39 million | Fiscal year 2009: -$2.27 million | Fiscal year 2008: $433.0 thousand | Fiscal year 2007: $212.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: